LXRX FY 2018 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$63M-30.0% YoY

Gross Profit

$61M96.1% margin

Operating Income

-$103M-163.4% margin

Net Income

-$121M-190.7% margin

EPS (Diluted)

$-1.14

Cash Flow

Operating Cash Flow

-$149M

Free Cash Flow

-$149M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$284M

Total Liabilities

$311M

Stockholders' Equity

-$1.5B

Cash & Equivalents

$160M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$63M	$90M	-30.0%
Gross Profit	$61M	$88M	-31.3%
Operating Income	-$103M	-$137M	+24.4%
Net Income	-$121M	-$129M	+6.6%